Associates of Cape Cod

Associates of Cape Cod, Inc. (ACC) is a specialized life sciences company with a dual focus on industrial quality control and clinical diagnostics. Its core business revolves around manufacturing Limulus Amebocyte Lysate (LAL) and recombinant reagents for bacterial endotoxin testing, alongside the Fungitell® assay for detecting fungal glucans in patient serum. The company demonstrates a strong commitment to sustainability, notably through its Horseshoe Crab Sustainability Project and the development of recombinant alternatives to traditional LAL. With a comprehensive portfolio spanning reagents, software (Pyros® eXpress), instrumentation compatibility, and contract services, ACC serves as an essential partner in ensuring drug safety and aiding in the diagnosis of life-threatening fungal infections.

Specialized biochemistry platform based on Limulus Amebocyte Lysate (LAL) for endotoxin detection and recombinant DNA technology for sustainable alternatives. Also, a diagnostic platform for detecting (1→3)-β-D-glucan as a biomarker for fungal infections.

Main competitors include Lonza and Charles River Laboratories in endotoxin testing, with differentiation based on ACC's long heritage, comprehensive service portfolio, and strong sustainability initiatives. In fungal glucan testing, ACC competes with other diagnostic assay providers, leveraging its integrated model of kit manufacturing and CLIA lab services.